公开(公告)号：US20240182552A1

公开(公告)日：2024-06-06

申请号：US18285862

申请日：2022-04-06

Applicant: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

Inventor： Dong Ho Nahm

IPC: C07K16/18 ,  A61K39/00 ,  A61P35/00 ,  A61P37/08 ,  C07K16/06

CPC classification number: C07K16/18 ,  A61P35/00 ,  A61P37/08 ,  C07K16/065 ,  A61K2039/505

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating immune dysregulation-related diseases, including oxidized immunoglobulin as an active ingredient and a preventive or therapeutic method using same, a pharmaceutical composition for treating allergic diseases, chronic inflammatory diseases, autoimmune diseases or malignant tumor diseases, including as an active ingredient oxidized immunoglobulin obtained through artificially induced oxidation; and a novel immunomodulatory therapy which, by administering the composition to patients with the diseases, is differentiated from existing immunoglobulin therapeutic agents and more effective.